CompletedPhase 2

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

NCT01491529

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novartis Investigative Site

Sunnyvale, California, United States

+38 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2012-04
Enrollment: 154 participants
Sponsor: Novartis Pharmaceuticals
Purpose: treatment

Locations (39)

Novartis Investigative SiteSunnyvale, California, United States
Novartis Investigative SiteEnglewood, Colorado, United States
Novartis Investigative SiteTampa, Florida, United States
Novartis Investigative SiteKansas City, Kansas, United States
Novartis Investigative SiteMilwaukee, Wisconsin, United States
Novartis Investigative SiteInnsbruck, Austria
Novartis Investigative SiteLinz, Austria
Novartis Investigative SiteVienna, Austria
Novartis Investigative SiteLondon, Ontario, Canada
Novartis Investigative SiteClermont-Ferrand, France
Novartis Investigative SiteLille, France
Novartis Investigative SitePessac, France
Novartis Investigative SitePoitiers, France
Novartis Investigative SiteBeelitz-Heilstätten, Germany
Novartis Investigative SiteBerlin, Germany
Novartis Investigative SiteBochum, Germany
Novartis Investigative SiteDüsseldorf, Germany
Novartis Investigative SiteKassel, Germany
Novartis Investigative SiteLeipzig, Germany
Novartis Investigative SiteMünchen, Germany
Novartis Investigative SiteMünchen, Germany
Novartis Investigative SiteStadtroda, Germany
Novartis Investigative SiteBudapest, Hungary
Novartis Investigative SiteKaposvár, Hungary
Novartis Investigative SiteSzeged, Hungary
Novartis Investigative SiteBrescia, BS, Italy
Novartis Investigative SiteBolzano, BZ, Italy
Novartis Investigative SitePisa, PI, Italy
Novartis Investigative SiteRoma, RM, Italy
Novartis Investigative SiteRoma, RM, Italy
Novartis Investigative SiteBratislava, Slovakia
Novartis Investigative SiteBratislava, Slovakia
Novartis Investigative SiteDonostia / San Sebastian, Basque Country, Spain
Novartis Investigative SiteBarcelona, Catalonia, Spain
Novartis Investigative SiteBarcelona, Catalonia, Spain
Novartis Investigative SiteSant Cugat del Vallès, Catalonia, Spain
Novartis Investigative SiteMadrid, Spain
Novartis Investigative SiteBern, Switzerland
Novartis Investigative SiteLausanne, Switzerland